Login
Toggle navigation
Videos
Categories
Trending
Ben McMillan, CIO of IDX Digital Assets, discusses crypto prices in the context of ongoing macroeconomic volatility.
00:10:00
Watch Full Video
×
Please Login to watch Full video
Login
+ ADD TO Wishlist
×
Please login
Login
Share On Facebook
Share On Twitter
Ben McMillan, CIO of IDX Digital Assets,
Recent Videos
00:17:08
Urasar is 100% Hayasa Metals Inc. owned; our exploration license over the Urasar mineral district
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold 1
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
Suggestions
00:10:00
Innovate Faster than Internet Giants|Hurst lin,General Partner, DCM
00:10:00
Enhancing Financial Value through Operational Excellence | Seth Brody, Partner, APAX Partners.
00:10:00
investors including Mary Meeker, Bond supports visionary founders throughout their life cycle of innovation and growth|Mood Rowghani,General Partner,Bond
00:10:00
Everything from recruiting to sales to improve your odds of success|Wei Lien Dang,General Partner,Unusual Ventures
00:10:00
CEO Rosario Pingaro Unveils Convergenze’s Story, Values, and Ambitious Fiber Optic Project in Sapri | Rosario Pingaro, CEO, Convergenze SpA Società Benefit.
00:00:00
Steven Lydeamore Chief Executive Officer, Immuron Ltd
00:10:00
Investing in India's Growth Story: Insights from Amar Kalkundrikar of Nippon India Mutual Fund | Amar Kalkundrikar - Fund Manager, Nippon India Mutual Fund
00:00:00
David Marsh Chief Executive Officer, Surgical Innovations Group
00:10:00
Companies That Transform: Alicorp Discusses Its Winning Initiative | Alfredo Perez Gubbins, CEO, ALi Corp3041:TAI
00:10:00
Deciphering the Economics and Dynamics of Wind Power Production | Xavier Barbaro, CEO, Neoen SA.
00:10:00
Everest Wealth Management - Expert Financial Advisors on "Die Groot Ontbyt"
00:10:00
Pursuit Minerals: Leading Vanadium Exploration and Development